Anti-Mullerian Hormone

"Anti-Mullerian Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.

Descriptor ID	D054304
MeSH Number(s)	D06.472.334.984.500
Concept/Terms	Anti-Mullerian Hormone Anti-Mullerian Hormone Anti Mullerian Hormone Antimullerian Hormone Mullerian Inhibiting Hormone Mullerian Inhibiting Substance Mullerian-Inhibitory Substance Mullerian Inhibitory Substance Mullerian-Inhibiting Factor Mullerian Inhibiting Factor Mullerian-Inhibiting Hormone Anti-Mullerian Factor Anti Mullerian Factor Mullerian Regression Factor

Below are MeSH descriptors whose meaning is more general than "Anti-Mullerian Hormone".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Gonadal Hormones [D06.472.334]
Testicular Hormones [D06.472.334.984]
Anti-Mullerian Hormone [D06.472.334.984.500]

Below are MeSH descriptors whose meaning is related to "Anti-Mullerian Hormone".

Below are MeSH descriptors whose meaning is more specific than "Anti-Mullerian Hormone".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-Mullerian Hormone" by people in this website by year, and whether "Anti-Mullerian Hormone" was a major or minor topic of these publications.

Bar chart showing 45 publications over 18 distinct years, with a maximum of 8 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	2	2
1994	0	2	2
1997	0	1	1
2002	0	2	2
2003	0	5	5
2004	0	2	2
2007	0	1	1
2012	1	0	1
2014	1	0	1
2015	1	0	1
2016	0	1	1
2017	1	0	1
2018	2	1	3
2019	2	1	3
2020	3	1	4
2021	7	1	8
2022	3	3	6
2023	1	0	1

Below are the most recent publications written about "Anti-Mullerian Hormone" by people in Profiles.

Santoro N, Flyckt R, Davis A, Finkelstein J, Crawford S, Sun F, Derby C, Morrison A, Sluss P, Zhang H. Anti-M?llerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause. Obstet Gynecol. 2023 02 01; 141(2):331-340.

View in: PubMed
Riepsamen AH, Donoghoe MW, Indran IR, Hechtman L, Robertson DM, Gilchrist RB, Ledger WL, Yong EL. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf). 2023 Apr; 98(4):567-577.

View in: PubMed
El Khoudary SR, Chen X, Qi M, Derby CA, Brooks MM, Thurston RC, Janssen I, Crawford S, Lee JS, Jackson EA, Chae CU, McConnell D, Matthews KA. The independent associations of anti-M?llerian hormone and estradiol levels over the menopause transition with lipids/lipoproteins: The Study of Women's health Across the Nation. J Clin Lipidol. 2023 Jan-Feb; 17(1):157-167.

View in: PubMed
Li H, Hart JE, Mahalingaiah S, Nethery RC, James P, Bertone-Johnson E, Eliassen AH, Laden F. Environmental Exposures and Anti-M?llerian Hormone: A Mixture Analysis in the Nurses' Health Study II. Epidemiology. 2023 01 01; 34(1):150-161.

View in: PubMed
Grimes NP, Whitcomb BW, Reeves KW, Sievert LL, Purdue-Smithe A, Manson JE, Hankinson SE, Rosner BA, Bertone-Johnson ER. The association between anthropometric factors and anti-M?llerian hormone levels in premenopausal women. Women Health. 2022 08; 62(7):580-592.

View in: PubMed
Grimes NP, Bertone-Johnson ER, Whitcomb BW, Sievert LL, Crawford SL, Gold EB, Avis NE, Greendale GA, Santoro N, Habel LA, Reeves KW. Anti-M?llerian hormone levels and breast cancer risk in the study of women's health across the nation. Cancer Causes Control. 2022 Aug; 33(8):1039-1046.

View in: PubMed
Zhou B, Kwan B, Desai MJ, Nalawade V, Ruddy KJ, Nathan PC, Henk HJ, Murphy JD, Whitcomb BW, Su HI. Long-term antim?llerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors. Fertil Steril. 2022 05; 117(5):1047-1056.

View in: PubMed
Langton CR, Whitcomb BW, Purdue-Smithe AC, Sievert LL, Hankinson SE, Manson JE, Rosner BA, Bertone-Johnson ER. Association of oral contraceptives and tubal ligation with antim?llerian hormone. Menopause. 2021 12 06; 29(2):225-230.

View in: PubMed
Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Bertone-Johnson E, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Liu M, Zeleniuch-Jacquotte A. Breast Cancer Risk Factors and Circulating Anti-M?llerian Hormone Concentration in Healthy Premenopausal Women. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4542-e4553.

View in: PubMed
Grimes NP, Whitcomb BW, Reeves KW, Sievert LL, Purdue-Smithe A, Manson JE, Hankinson SE, Rosner BA, Bertone-Johnson ER. The association of parity and breastfeeding with anti-M?llerian hormone levels at two time points. Maturitas. 2022 Jan; 155:1-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals